Article thumbnail

Nonresponse to Interferon-? Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis

By Cozen M.L., Ryan J.C., Shen H., Lerrigo R., Yee R.M., Sheen E., Wu R. and Monto A.


10.1371/journal.pone.0061568PLoS ONE84e6156

Topics: alpha interferon, peginterferon alpha, ribavirin, alpha interferon, adult, aged, article, clinical assessment, controlled study, disease association, drug treatment failure, female, follow up, hepatitis C, human, human tissue, liver biopsy, liver cirrhosis, liver fibrosis, major clinical study, male, overall survival, patient attitude, retrospective study, risk assessment, risk factor, treatment outcome, complication, disease course, Hepatitis C, Chronic, liver cirrhosis, middle aged, recurrent disease, reproducibility, survival, time, treatment failure, Hepatitis C virus, Aged, Disease Progression, Female, Hepatitis C, Chronic, Humans, Interferon-alpha, Liver Cirrhosis, Male, Middle Aged, Recurrence, Reproducibility of Results, Retrospective Studies, Risk Factors, Survival Analysis, Time Factors, Treatment Failure
Publisher: 'Public Library of Science (PLoS)'
Year: 2013
DOI identifier: 10.1371/journal.pone.0061568
OAI identifier:
Provided by: ScholarBank@NUS
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)

  • To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

    Suggested articles